摘要
目的探讨预防性应用微生态制剂（贝飞达）对小儿肺炎继发腹泻的防治效果。方法2000年1月～2007年12月住院治疗的肺炎患儿360例随机分为预防组和对照组。预防组在入院后即开始应用微生态制剂；对照组入院后始终未用或住院时间72h后因出现继发腹泻才开始应用微生态制剂。对肺炎继发腹泻的发生率和治疗效果进行统计分析。结果预防组186例住院治疗期间继发腹泻病发病率为20．97％（39／186）；对照组174例住院治疗期间继发腹泻病的发病率40．80％（71／174），两组间差异具有统计学意义（X^2=16．672，P〈0．01），而腹泻的治疗疗效，预防组也明显优于对照组。结论预防性应用微生态制剂（贝飞达）能减低肺炎患儿继发腹泻的发生率，并对腹泻有较好的治疗效果。
Objective To study the prevention and treatment effect of microecological modulator （Bifid） used in advance on pneumonic infants with secondary diarrhea. Methods 360 pneumonic infants in hospital from Jan, 2000 to Dec , 2007 were randomly divided into defend group and control group. The infants who used microecological modulator as soon as after being in hospital with the time of dosing beyond 72 hours were put into the defend group ; the infants who never used microecological modulator after being in hospital or used microecological modulator because of pneumonia with secondary diarrhea after 72 hours in hospital were put into control group. The ratio of diarrhea and the therapeutic efficacy were statistical analysised. Results The defend group of 186 cases used Bifid to prevent and cure diarrhea , and the ratio of diarrhea during treatment in hospital was 20.97 %（39/186）; while the control group of 174 cases didn＇t use Bifid , and the ratio was 40.80% （71/174）. The difference between two groups had statistic significance（ X^2=16.672, P〈0.01）.And the therapeutic efficacy of defend group was better than control group. Conclusions Microecological modulator （Peifeikang） used in advance can decrease the ratio of secondary diarrhea on pneumonia infants.
出处
《国际医药卫生导报》
2008年第16期68-71,共4页
International Medicine and Health Guidance News
关键词
肺炎
腹泻
微生态制剂
儿童
Pneumonia Diarrhea Microecological modulator Infants
